enVVeno Medical (NVNO) Accumulated Expenses (2017 - 2026)

enVVeno Medical's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $382000.0 for Q1 2026.

• On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $382000.0 in Q1 2026; TTM through Mar 2026 was $382000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.7 million, up 186.75% from the prior year.
• Accumulated Expenses slipped to $382000.0 in Q1 2026 per NVNO's latest filing, from $1.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.7 million in Q4 2025 and bottomed at $294000.0 in Q1 2022.
• The 4-year median for Accumulated Expenses is $495000.0 (2022), against an average of $635571.4.
• Across the five-year window, Accumulated Expenses tumbled 44.71% in 2022 and soared 186.75% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $568000.0 in 2022, then gained by 6.34% to $604000.0 in 2024, then jumped by 186.75% to $1.7 million in 2025, then slumped by 77.94% to $382000.0 in 2026.
• Per Business Quant, the three latest NVNO Accumulated Expenses figures stand at $382000.0 (Q1 2026), $1.7 million (Q4 2025), and $604000.0 (Q4 2024).